Journal of Cancer Research and Clinical Oncology

, Volume 129, Issue 12, pp 676–682

Comparison of health-related quality of life and prostate-associated symptoms after primary and salvage cryotherapy for prostate cancer

  • Aristotelis G. Anastasiadis
  • Reena Sachdev
  • Laurent Salomon
  • Mohamed A. Ghafar
  • Brian C. Stisser
  • Ridwan Shabsigh
  • Aaron E. Katz
Original Paper

Abstract

Purpose

Recent advances in cryosurgery of the prostate have led to the ability to treat tumors successfully with decreased morbidity. The patients’ perspectives of this relatively new technique, however, have not yet been addressed. The purpose of this study was to compare health related quality of life (QoL) as well as prostate-associated symptoms in patients after primary and salvage cryoablation for clinically localized prostate cancer using a self-administered questionnaire.

Methods

A total of 131 consecutive patients who underwent cryoablation of the prostate between 1997 and 2001 were included in this confidential mailing study. The patients were either (a) patients with localized prostate cancer with contraindications for radical surgery, including patients refusing other forms of therapy, or (b) had locally recurrent prostate cancer after failure of radiation therapy. All patients received 3 months of neoadjuvant androgen deprivation therapy prior to cryosurgery and were surgically treated by the same surgeon using an argon-based system. We used the EORTC QLQ-C30, a commonly used, multidimensional instrument together with a supplementing, prostate-cancer-specific module.

Results

Eighty-one of the 131 patients (response rate 62%) returned the questionnaires. The two groups were comparable regarding age (mean age 72.8 vs 70.1 for the primary and the salvage group, respectively; p=0.22). The overall QoL scores were high in both groups. Primary cryotherapy patients fared significantly better regarding physical (p=0.005) and social (p=0.024) functioning compared with salvage cryotherapy patients. The most prominent prostate-related symptom in both patient groups was sexual dysfunction, followed by urinary symptoms, which were significantly more severe in the salvage group (p=0.001). Incontinence rates were 5.9 and 10% in the primary and the salvage group, respectively. Severe erectile dysfunction was reported in 86 and 90% of the primary and the salvage group, respectively.

Conclusions

The present study demonstrates that, in selected patients, cryotherapy is a treatment option which has a functional outcome comparable to traditionally used prostate cancer treatments. More information regarding QoL is necessary for appropriate patient counseling and individual decision-making in the presence of various treatment alternatives.

Keywords

Prostate cancer Cryotherapy Quality of life Functional results Sexual dysfunction 

References

  1. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, Kaasa S, Klee MC, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw KCA, Sullivan M, Takeda F (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376PubMedGoogle Scholar
  2. American Cancer Society (2003) Cancer Facts and Figures 2003. Accessed through the World Wide Web: http://www.cancer.org/docroot/STT/stt_0.asp (Date of Access: 24 April 2003)Google Scholar
  3. Bahn DK, Lee F, Badalament R, Kumar A, Greski J, Chernick M (2002) Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology 60 (Suppl 1):3–11CrossRefPubMedGoogle Scholar
  4. Borghede G, Sullivan M (1996) Measurement of quality of life in localized prostatic cancer patients treated with radiotherapy. Development of a prostate cancer-specific module supplementing the EORTC QLQ-C30. Qual Life Res 5:212–222PubMedGoogle Scholar
  5. Chin JL, Pautler SE, Mouraviev V, Touma N, Moore K, Downey DB (2001) Results of salvage cryoablation of the prostate after radiation: identifying predictors of treatment failure and complications. J Urol 165:1937–1941PubMedGoogle Scholar
  6. Donnelly BJ, Saliken JC, Ernst DS, Ali-Ridha N, Brasher PM, Robinson JW, Rewcastle JC (2002) Prospective trial of cryosurgical ablation of the prostate: 5-year results. Urology 60:645–649CrossRefPubMedGoogle Scholar
  7. Efficace F, Bottomley A, van Andel G (2003) Health related quality of life in prostate carcinoma patients: a systematic review of randomized controlled trials. Cancer 97:377–388CrossRefPubMedGoogle Scholar
  8. Ellis DS (2002) Cryosurgery as primary treatment for localized prostate cancer: a community hospital experience. Urology 60 (Suppl 1):34–39CrossRefPubMedGoogle Scholar
  9. Fayers P, Bottomley A (2002) Quality of life research within the EORTC-the EORTC QLQ-C30. European Organisation for Research and Treatment of Cancer. Eur J Cancer 38 (Suppl 4):S125–S133CrossRefPubMedGoogle Scholar
  10. Fayers P, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A (2001) The EORTC QLQ-C30 Scoring Manual, 3rd edn. European Organisation for Research and Treatment of Cancer, BrusselsGoogle Scholar
  11. Fransson P, Damber JE, Tomic R, Modig H, Nyberg G, Widmark A (2001) Quality of life and symptoms in a randomized trial of radiotherapy versus deferred treatment of localized prostate carcinoma. Cancer 92:3111–3119CrossRefPubMedGoogle Scholar
  12. Ganz PA, Rowland JH, Desmond K, Meyerowitz BE, Wyatt GE (1998) Life after breast cancer: understanding women’s health-related quality of life and sexual functioning. J Clin Oncol 16:501–514PubMedGoogle Scholar
  13. Ghafar MA, Johnson CW, Taille A de la, Benson MC, Bagiella E, Fatal M, Olsson CA, Katz AE (2001) Salvage cryotherapy using an argon based system for locally recurrent prostate cancer after radiation therapy: the Columbia experience. J Urol 166:1333–1337PubMedGoogle Scholar
  14. Gonder MJ, Soanes WA, Shulman S (1966) Cryosurgical treatment of the prostate. Invest Urol 3:372–378PubMedGoogle Scholar
  15. Izawa JI, Madsen LT, Scott SM, Tran JP, McGuire EJ, Eschenbach AC von, Pisters LL (2002) Salvage cryotherapy for recurrent prostate cancer after radiotherapy: variables affecting patient outcome. J Clin Oncol 20:2664–2671CrossRefPubMedGoogle Scholar
  16. Litwin MS, Lubeck DP, Henning JM, Carroll PR (1998) Differences in urologist and patient assessments of health related quality of life in men with prostate cancer: results of the CaPSURE database. J Urol 159:1988–1992PubMedGoogle Scholar
  17. Long JP, Bahn D, Lee F, Shinohara K, Chinn DO, Macaluso JN Jr (2001) Five-year retrospective, multi-institutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostate. Urology 57:518–523CrossRefPubMedGoogle Scholar
  18. Moul JW (1999) Rising PSA after local therapy failure: immediate vs deferred treatment. Oncology 13:985–990PubMedGoogle Scholar
  19. Onik GM, Cohen JK, Reyes GD, Rubinsky B, Chang Z, Baust J (1993) Transrectal ultrasound-guided percutaneous radical cryosurgical ablation of the prostate. Cancer 72:1291–1299PubMedGoogle Scholar
  20. Onik G, Narayan P, Vaughan D, Dineen M, Brunelle R (2002) Focal “nerve-sparing” cryosurgery for treatment of primary prostate cancer: a new approach to preserving potency. Urology 60:109–114CrossRefGoogle Scholar
  21. Perrotte P, Litwin MS, McGuire EJ, Scott SM, Eschenbach AC von, Pisters LL (1999) Quality of life after salvage cryotherapy: the impact of treatment parameters. J Urol 162:398–402PubMedGoogle Scholar
  22. Robinson JW, Donnelly BJ, Saliken JC, Weber BA, Ernst S, Rewcastle JC (2002) Quality of life and sexuality of men with prostate cancer 3 years after cryosurgery. Urology 60:12–18CrossRefGoogle Scholar
  23. Shrader-Bogen CL, Kjellberg JL, McPherson CP, Murray CL (1997) Quality of life and treatment outcomes: prostate carcinoma patients’ perspectives after prostatectomy or radiation therapy. Cancer 79:1977–1986CrossRefPubMedGoogle Scholar
  24. Taille A de la, Benson MC, Bagiella E, Burchardt M, Shabsigh A, Olsson CA, Katz AE (2000a) Cryoablation for clinically localized prostate cancer using an argon-based system: complication rates and biochemical recurrence. Br J Urol Int 85:281–286Google Scholar
  25. Taille A de la, Hayek O, Benson MC, Bagiella E, Olsson CA, Fatal M, Katz AE (2000b) Salvage cryotherapy for recurrent prostate cancer after radiation therapy: the Columbia experience. Urology 55:79–84CrossRefPubMedGoogle Scholar
  26. Tefilli MV, Gheiler EL, Tiguert R, Barroso U Jr, Barton CD, Wood DP Jr, Pontes JE (1998) Quality of life in patients undergoing salvage procedures for locally recurrent prostate cancer. J Surg Oncol 69:156–161CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2003

Authors and Affiliations

  • Aristotelis G. Anastasiadis
    • 1
  • Reena Sachdev
    • 1
  • Laurent Salomon
    • 1
  • Mohamed A. Ghafar
    • 1
  • Brian C. Stisser
    • 1
  • Ridwan Shabsigh
    • 1
  • Aaron E. Katz
    • 1
  1. 1.Department of UrologyColumbia University Health SciencesNew YorkUSA

Personalised recommendations